Smith R E, Strieter R M, Zhang K, Phan S H, Standiford T J, Lukacs N W, Kunkel S L
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA.
J Leukoc Biol. 1995 May;57(5):782-7. doi: 10.1002/jlb.57.5.782.
Pulmonary fibrosis is the end point of a chronic inflammatory process characterized by leukocyte recruitment and activation, fibroblast proliferation, and increased extracellular matrix production. Previous studies of models of pulmonary fibrosis have investigated the role of cytokines in the evolution of the fibrotic response. The involvement of tumor necrosis factor and interleukin-1 in bleomycin-induced lung injury, a model of idiopathic pulmonary fibrosis, has been well established, suggesting that cytokines mediate the initiation and maintenance of chronic inflammatory lesions. However, the aforementioned cytokines alone cannot account for the recruitment and activation of specific leukocyte populations found in the bleomycin model. Recently, a family of novel proinflammatory cytokines (chemokines) was cloned and characterized, yielding many putative mediators of leukocyte functions. Macrophage inflammatory protein-1 alpha (MIP-1 alpha) and monocyte chemoattractant protein-1 (MCP-1) belong to the C-C chemotactic cytokine family, a group of low-molecular-weight peptides. These molecules modulate chemotaxis, proliferation, and cytokine expression in leukocyte subsets. Our group has investigated the roles of MCP-1 and MIP-1 alpha in the bleomycin model. Both MCP-1 and MIP-1 alpha are expressed in a time-dependent manner after bleomycin challenge, and passive immunization of these animals with either anti-MIP-1 alpha or anti-MCP-1 antibodies attenuated leukocyte accumulation. In addition, we have identified specific cell types expressing MCP-1 or MIP-1 alpha by in situ hybridization and immunohistochemical localization, respectively. Furthermore, our results indicate that MIP-1 alpha expression is mediated by alveolar macrophage-derived tumor necrosis factor, identifying an important cytokine pathway in the initiation of pulmonary fibrosis. Finally, anti-MIP-1 alpha therapy attenuated fibrosis, providing direct evidence for its involvement in fibrotic pathology. Our work has clearly established that the C-C chemokines MCP-1 and MIP-1 alpha are expressed and contribute to the initiation and maintenance of the bleomycin-induced pulmonary lesion.
肺纤维化是一种慢性炎症过程的终点,其特征为白细胞募集和激活、成纤维细胞增殖以及细胞外基质产生增加。先前对肺纤维化模型的研究探讨了细胞因子在纤维化反应演变中的作用。肿瘤坏死因子和白细胞介素 -1 在博来霉素诱导的肺损伤(一种特发性肺纤维化模型)中的作用已得到充分证实,这表明细胞因子介导了慢性炎症病变的起始和维持。然而,仅上述细胞因子无法解释博来霉素模型中特定白细胞群体的募集和激活。最近,一类新型促炎细胞因子(趋化因子)被克隆并鉴定,产生了许多白细胞功能的假定介质。巨噬细胞炎性蛋白 -1α(MIP -1α)和单核细胞趋化蛋白 -1(MCP -1)属于C - C趋化细胞因子家族,这是一组低分子量肽。这些分子调节白细胞亚群中的趋化性、增殖和细胞因子表达。我们的研究小组研究了MCP -1和MIP -1α在博来霉素模型中的作用。博来霉素攻击后,MCP -1和MIP -1α均呈时间依赖性表达,用抗MIP -1α或抗MCP -1抗体对这些动物进行被动免疫可减轻白细胞积聚。此外,我们分别通过原位杂交和免疫组化定位确定了表达MCP -1或MIP -1α的特定细胞类型。此外,我们的结果表明MIP -1α表达由肺泡巨噬细胞衍生的肿瘤坏死因子介导,确定了肺纤维化起始过程中的一条重要细胞因子途径。最后,抗MIP -1α治疗减轻了纤维化,为其参与纤维化病理提供了直接证据。我们的工作清楚地表明,C - C趋化因子MCP -1和MIP -1α表达并促成了博来霉素诱导的肺部病变的起始和维持。